N-α –Fmoc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-D-2,3-diaminopropionic acid

N-α -Fmoc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-D-2,3-diaminopropionic acid is a D-configured, diamino-propionic acid derivative designed for peptide chemistry, bearing an Fmoc-protected alpha-amino group that supports base-labile deprotection in solid-phase or solution-phase workflows. The molecule incorporates a second amino functionality within the D-2,3-diaminopropionic framework and a cyclic, 2,6-dioxocyclohex-1-ylidene substituent on the β-position, which introduces a rigid, conjugated acyl-like motif that can participate in controlled derivatization and subsequent functional group transformations. The presence of an acid (carboxylic acid) together with protected and unprotected amines creates a defined reactivity profile for selective peptide coupling and orthogonal protection strategies. The stereochemical definition at the diamino backbone and the bulky, conformationally directing substituent make it suitable as a chiral amino acid intermediate and as a functionalized building block for constructing constrained peptide analogs and downstream synthetic intermediates.

1. Protected Amino Acid Chemistry

N-α -Fmoc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-D-2,3-diaminopropionic acid is applied in protected amino acid synthesis and orthogonal protection planning for peptide-grade intermediates. The Fmoc group on the alpha-amino site enables standard peptide coupling after activation of the carboxyl group, while the D-2,3-diaminopropionic motif provides a second amino handle that can be selectively protected or left available for orthogonal derivatization. The β-substituent containing the 4,4-dimethyl-2,6-dioxocyclohex-1-ylidene unit can undergo further functional group manipulation, including conversion to reactive carbonyl derivatives or incorporation into constrained scaffolds. Downstream, the compound can serve as a chiral intermediate for preparing N-protected amino acid derivatives and for tuning side-chain electronics and steric environment in peptide synthesis.

2. Peptide Synthesis

N-α -Fmoc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-D-2,3-diaminopropionic acid supports peptide building block preparation where a constrained, stereodefined diamino acid residue is required. The Fmoc-protected alpha-amine provides compatibility with common peptide coupling chemistries, while the free or selectively protected second amino group can be used to introduce branching, additional amide formation, or orthogonal functionalization during sequential assembly. The rigid cyclic dioxo substituent at the β-position can influence local conformation and can be retained through coupling steps to generate peptidomimetic structures with defined backbone geometry. The resulting peptide analogs can be used for structure-activity relationship studies, conformational probing, and synthetic methodology development in amino acid and peptide chemistry.

3. Peptidomimetics And SAR

N-α -Fmoc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-D-2,3-diaminopropionic acid is employed in peptidomimetic construction for structure-activity relationship investigations that require stereochemical control and side-chain constraint. The D-configuration within the diamino-propionic acid backbone enables incorporation of a defined chiral center pattern that can alter protease recognition and conformational preferences in peptide-like scaffolds. The β-ylidene cyclic dioxo motif functions as a rigid, carbonyl-rich substituent that can modulate hydrogen-bonding capacity and electronic distribution, supporting rational analog design. Subsequent derivatization of the remaining amino functionality can generate libraries of constrained analogs for SAR studies, fragment refinement, and molecular design campaigns in applied medicinal chemistry workflows.

4. Chemical Biology Conjugation

N-α -Fmoc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-D-2,3-diaminopropionic acid can be used in chemical biology for biomolecule modification where controlled functional group placement is critical. The combination of a protected alpha-amino group for stepwise synthesis and an additional amino functionality allows preparation of conjugation-ready peptide fragments that can be coupled to targeting ligands, linkers, or affinity handles. The cyclic dioxo substituent provides a carbonyl-rich region that may serve as a handle for further chemical conversion to reactive intermediates or for incorporation into stable linkages during conjugate assembly. Downstream, the compound can feed into the synthesis of labeled peptides, affinity probes, and engineered biomolecule fragments used to interrogate binding interfaces, receptor interactions, or enzyme-substrate recognition in biochemical research.

5. Process Chemistry Intermediate

N-α -Fmoc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-D-2,3-diaminopropionic acid is suitable for process chemistry intermediate preparation where scalable peptide building blocks and chiral amino acid derivatives are required. The Fmoc-protected amino functionality supports predictable deprotection behavior under base conditions, while the carboxylic acid group enables standard activation and coupling steps that can be translated into manufacturing workflows for protected amino acid chemistry. The stereodefined D-diaminopropionic framework and the bulky cyclic dioxo substituent can help maintain structural integrity during multi-step synthesis, supporting downstream conversion into peptide-grade intermediates and constrained analogs. Industrially, the compound can be employed as a defined chiral input for fine chemical synthesis, enabling reproducible construction of functionalized peptide fragments used in research-grade materials and specialty chemical production.

6. Analytical Research Standards

N-α -Fmoc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-D-2,3-diaminopropionic acid is applicable to analytical research and method development where structurally defined amino acid derivatives are needed as standards or reference fragments. The presence of Fmoc and the characteristic cyclic dioxo β-substituent provides distinct chromatographic and spectroscopic signatures that can support LC-MS identification, fragmentation interpretation, and impurity profiling during peptide synthesis and intermediate handling. The defined D-stereochemistry and the diamino-propionic backbone can be used to benchmark stereochemical integrity in synthetic sequences and to monitor orthogonal protection performance. Downstream, the compound can serve as a reference material for quality control of peptide building block preparations, supporting reliable characterization of protected amino acid derivatives and their coupled products.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

4. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

5. TMEM16F and dynamins control expansive plasma membrane reservoirs